Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01810848 · ClinicalTrials.gov registry record · Phase 1
Pilot Study of Therapy With Hylan G-F 20 Exercise Capacity
A Phase 1 study, sponsored by OhioHealth.
- Terminated
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
NCT01810848 is a Phase 1 study that was terminated before completion, run by OhioHealth. The registered enrollment target is 9 participants.
The verdict
NCT01810848, a Phase 1 study, was terminated before completion, sponsored by OhioHealth.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
Osteoarthritis of the knee is a degenerative joint disease that involves degradation of the joint. Symptoms include joint tenderness, pain, stiffness, locking, and occasionally an effusion. Over 40 million Americans also have cardiovascular disease in addition to their OA. Initiation and maintenance of even low-levels of physical activity is critical for management of cardiac risk. Patients with osteoarthritis have been shown to have poorer aerobic conditioning, lower daily physical activity levels and lower self-efficacy for exercise than non-OA cohorts. It has been established that there exists a consistent gradient across activity groups indicating greater longevity and reduced risk of CHD, CVD, and stroke, in more active individuals. Available research suggests the greatest gains in cardiovascular fitness occur in moving a sedentary individual to even low levels of physical activity, and 12 weeks is enough to demonstrate change in the risk profile of at-risk individuals. Finally, appropriate levels of aerobic and strength training have been shown to be beneficial in treatment of osteoarthritis of the knee. This study will evaluate the effectiveness of hylan G-F 20 (single injection preparation) in promoting greater levels of physical activity and fitness as measured by MET level compared to an exercise-only cohort; evaluating both the change in physical function as well as the cardiovascular risk profile. This is a randomized, single-blinded clinical trial comparing injection of the knee joint with Hylan GF-20 to sham procedure. Subjects will undergo a regular exercise program for 6 months following randomization.
Interventions
- OTHER Control
- DEVICE Hylan G-F 20
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2014-06 |
| Est. Completion | 2015-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01810848
The ClinicalTrials.gov registry entry for NCT01810848 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is OhioHealth, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT01810848 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01810848 about?
NCT01810848 is a clinical study titled "Pilot Study of Therapy With Hylan G-F 20 Exercise Capacity". Osteoarthritis of the knee is a degenerative joint disease that involves degradation of the joint. Symptoms include joint tenderness, pain, stiffness, locking, and occasionally an effusion. Over 40 million Americans also have cardiovascular disease in addition to their OA. Initiation and maintenance...
What is the current status of trial NCT01810848?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2014-06. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01810848?
The interventions under investigation include: Control (OTHER), Hylan G-F 20 (DEVICE).
Who is sponsoring clinical trial NCT01810848?
This trial is sponsored by OhioHealth, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.